Pomalyst

Active Ingredient(s): Pomalidomide
FDA Approved: * February 8, 2013
Pharm Company: * CELGENE
Category: Cancer

Pomalidomide (INN; marketed as Pomalyst in the US[3] and Imnovid in the European Union and Russia) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator.[medical citation needed] Pomalidomide was approved in February 2013, by the US Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.[6] It has been approved for use in people who have received at ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Pomalyst 1 mg Oral Capsule
NDC: 59572-501
Labeler:
Celgene Corporation
Pomalyst 2 mg Oral Capsule
NDC: 59572-502
Labeler:
Celgene Corporation
Pomalyst 3 mg Oral Capsule
NDC: 59572-503
Labeler:
Celgene Corporation
Pomalyst 4 mg Oral Capsule
NDC: 59572-504
Labeler:
Celgene Corporation

Popular Topics

Pomalyst

Started about a year ago after revlimid quit working. Still adjusting the dosage. Gone from 4 to 1 to 2 to 3 mg. Mostly ...